Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive AdultsJournal of acquired immune deficiency syndromes (1999), 2013-08, Vol.63 (4), p.449-455 [Peer Reviewed Journal]2013 Lippincott Williams & Wilkins, Inc. ;2014 INIST-CNRS ;Copyright Lippincott Williams & Wilkins Aug 1, 2013 ;ISSN: 1525-4135 ;EISSN: 1944-7884 ;DOI: 10.1097/QAI.0b013e3182965d45 ;PMID: 23807155 ;CODEN: JDSRETFull text available |
|
2 |
Material Type: Article
|
N6-methyl-adenine: an epigenetic signal for DNA-protein interactionsNature reviews. Microbiology, 2006-03, Vol.4 (3), p.183-192 [Peer Reviewed Journal]Copyright Nature Publishing Group Mar 2006 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1740-1526 ;EISSN: 1740-1534 ;DOI: 10.1038/nrmicro1350 ;PMID: 16489347Full text available |
|
3 |
Material Type: Article
|
Implications of efficient hepatic delivery by tenofovir alafenamide (GS-7340) for hepatitis B virus therapyAntimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.3563-3569 [Peer Reviewed Journal]Copyright © 2015, American Society for Microbiology. All Rights Reserved. ;Copyright © 2015, American Society for Microbiology. All Rights Reserved. 2015 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/aac.00128-15 ;PMID: 25870059Full text available |
|
4 |
Material Type: Article
|
The ADP/ATP translocator is not essential for the mitochondrial permeability transition poreNature, 2004-01, Vol.427 (6973), p.461-465 [Peer Reviewed Journal]2005 INIST-CNRS ;COPYRIGHT 2004 Nature Publishing Group ;Copyright Macmillan Journals Ltd. Jan 29, 2004 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature02229 ;PMID: 14749836 ;CODEN: NATUASFull text available |
|
5 |
Material Type: Article
|
N6-Furfuryladenine is protective in Huntington’s disease models by signaling huntingtin phosphorylationProceedings of the National Academy of Sciences - PNAS, 2018-07, Vol.115 (30), p.E7081-E7090 [Peer Reviewed Journal]Volumes 1–89 and 106–115, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright National Academy of Sciences Jul 24, 2018 ;2018 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1801772115 ;PMID: 29987005Full text available |
|
6 |
Material Type: Article
|
Pharmacokinetics of long-acting tenofovir alafenamide (GS-7340) subdermal implant for HIV prophylaxisAntimicrobial agents and chemotherapy, 2015-07, Vol.59 (7), p.3913-3919 [Peer Reviewed Journal]Copyright © 2015, American Society for Microbiology. All Rights Reserved. ;Copyright © 2015, American Society for Microbiology. All Rights Reserved. 2015 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.00656-15 ;PMID: 25896688Full text available |
|
7 |
Material Type: Article
|
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African WomenThe New England journal of medicine, 2015-02, Vol.372 (6), p.509-518 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;Copyright © 2015 Massachusetts Medical Society 2015 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1402269 ;PMID: 25651245Full text available |
|
8 |
Material Type: Article
|
Inhibition of B-cell lymphoma 2 family proteins alters optical redox ratio, mitochondrial polarization, and cell energetics independent of cell stateJournal of biomedical optics, 2022-05, Vol.27 (5), p.056505-056505 [Peer Reviewed Journal]The Authors. Published by SPIE under a Creative Commons Attribution 4.0 International License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI. ;2022. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 The Authors 2022 The Authors ;ISSN: 1083-3668 ;EISSN: 1560-2281 ;DOI: 10.1117/1.JBO.27.5.056505 ;PMID: 35643815Full text available |
|
9 |
Material Type: Article
|
An Adversarial DNA N 6 -Methyladenine-Sensor Network Preserves Polycomb SilencingMolecular cell, 2019-06, Vol.74 (6), p.1138 [Peer Reviewed Journal]Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 1097-4164 ;DOI: 10.1016/j.molcel.2019.03.018 ;PMID: 30982744Full text available |
|
10 |
Material Type: Article
|
Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesisNature (London), 2019-07, Vol.571 (7764), p.275-278 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Jul 11, 2019 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-019-1314-0 ;PMID: 31181567Full text available |
|
11 |
Material Type: Article
|
MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartmentsPloS one, 2013-01, Vol.8 (1), p.e55013 [Peer Reviewed Journal]COPYRIGHT 2013 Public Library of Science ;COPYRIGHT 2013 Public Library of Science ;2013. This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0055013 ;PMID: 23383037Full text available |
|
12 |
Material Type: Article
|
Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adultsJournal of antimicrobial chemotherapy, 2014-05, Vol.69 (5), p.1362-1369 [Peer Reviewed Journal]Copyright Oxford Publishing Limited(England) May 2014 ;ISSN: 0305-7453 ;EISSN: 1460-2091 ;DOI: 10.1093/jac/dkt532 ;PMID: 24508897Full text available |
|
13 |
Material Type: Article
|
Cellular and Molecular Mechanisms of Kidney Injury in 2,8-Dihydroxyadenine NephropathyJournal of the American Society of Nephrology, 2020-04, Vol.31 (4), p.799-816 [Peer Reviewed Journal]Copyright © 2020 by the American Society of Nephrology. ;Copyright © 2020 by the American Society of Nephrology 2020 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/asn.2019080827 ;PMID: 32086278Full text available |
|
14 |
Material Type: Article
|
Long-term renal outcomes of APRT deficiency presenting in childhoodPediatric nephrology (Berlin, West), 2019-03, Vol.34 (3), p.435-442 [Peer Reviewed Journal]IPNA 2018 ;COPYRIGHT 2019 Springer ;Pediatric Nephrology is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0931-041X ;EISSN: 1432-198X ;DOI: 10.1007/s00467-018-4109-x ;PMID: 30443743Full text available |
|
15 |
Material Type: Article
|
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenThe New England journal of medicine, 2010-12, Vol.363 (27), p.2587-2599 [Peer Reviewed Journal]Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1011205 ;PMID: 21091279 ;CODEN: NEJMAGFull text available |
|
16 |
Material Type: Article
|
Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE StudyJournal of clinical oncology, 2021-12, Vol.39 (34), p.3853-3865 [Peer Reviewed Journal]2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.00807 ;PMID: 34618601Full text available |
|
17 |
Material Type: Article
|
Rossmann-toolbox: a deep learning-based protocol for the prediction and design of cofactor specificity in Rossmann fold proteinsBriefings in bioinformatics, 2022-01, Vol.23 (1) [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2021 ;The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com ;ISSN: 1467-5463 ;EISSN: 1477-4054 ;DOI: 10.1093/bib/bbab371 ;PMID: 34571541Full text available |
|
18 |
Material Type: Article
|
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 StudyJournal of acquired immune deficiency syndromes (1999), 2015-08, Vol.69 (4), p.439-445 [Peer Reviewed Journal]Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. ;Copyright Lippincott Williams & Wilkins Aug 1, 2015 ;ISSN: 1525-4135 ;EISSN: 1944-7884 ;DOI: 10.1097/QAI.0000000000000618 ;PMID: 25867913 ;CODEN: JDSRETFull text available |
|
19 |
Material Type: Article
|
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström MacroglobulinemiaJournal of clinical oncology, 2021-02, Vol.39 (6), p.565-575 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.00555 ;PMID: 32931398Full text available |
|
20 |
Material Type: Article
|
Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissuesJournal of antimicrobial chemotherapy, 2017-06, Vol.72 (6), p.1731-1740 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2017 ;ISSN: 0305-7453 ;EISSN: 1460-2091 ;DOI: 10.1093/jac/dkx064 ;PMID: 28369415Full text available |